April 24, 2024
Humana Bounced Back But Has Challenges Humana’s Q1 2024 investor call was better than its Q4 one. It reported better results, including a slightly improved medical loss ratio for its large Medicare Advantage (MA) business. Costs seem to be coming down but the delay in claims due to the cyberattack could cause a re-evaluation. Humana projects flat margins in 2024 and long-term margins to decline to a floor of 3%, which is noticeably down. It will cut $700 million in response in 2024. It pulled its 2025 projections for now. It continued to note that the 2025 rate hike will mean reductions in benefits and retreating in some geographies. Additional article: https://www.modernhealthcare.com/finance/humana-medicare-advantage-profit-2024 and https://www.healthcaredive.com/news/humana-withdraws-2025-earnings-outlook-q1-2024/714105/ and https://www.beckerspayer.com/payer/humana-reported-741-million-in-net-income-in-the-first-quarter-of-2024.html and https://www.beckerspayer.com/payer/humana-plans-to-leave-some-medicare-advantage-markets-in-2025.html (Some articles may require a subscription.) #humana #medicareadvantage https://www.fiercehealthcare.com/payers/humana-confirms-2024-guidance-even-it-beats-street-q1 Notable Layoffs Hitting Healthcare These are not the first announced layoffs due to tightening times, but more announcements have come. Optum has laid